breaking news E

Dr. J Antony Prince, Founder & CEO, Memsift Innovations Pte Ltd (Left) and Dr. Jeffrey McCutcheon, Executive Director, CCAST (Right)

Singapore: Memsift Innovations Pte Ltd and the Connecticut Center for Applied Separations Technologies (CCAST) at the University of Connecticut (UConn) have executed a cooperation agreement in the form of Memorandum of Understanding (MOU) to explore application studies and pilot trials for Memsift technologies in North America.

Memsift’s thermal separation process and membranes are based on innovative patented technologies that provide unique benefits over traditional brine treatment and zero liquid discharge solutions. Memsift’s TS-30™ system uses an innovative thermodynamic principle-based thermal separation process and a proprietary membrane STOMATE® that brings down the industrial effluent treatment costs significantly. Memsift has received interests in its product and its applications from North America. Memsift determined to explore the potential markets and applications for its products in the region. It would be advantageous to appoint a strategic partner who possesses the technical understanding and analytical facilities to perform the application studies and pilot trials to validate the product for its initial customers in the United State of America (USA).

The Connecticut Center for Applied Separations Technologies at the University of Connecticut is highly regarded in North America for its membrane separation expertise and experience, particularly related to membrane distillation. As a result, CCAST is a strong partner for testing and or validating third-party applications as well as for performing application studies and or pilot trials for North American companies interested in utilizing Memsift technologies. This third-party testing service will support Memsift’s commercialization efforts and early-stage adoption in North America.

Dr. J. Antony Prince, Founder & CEO, Memsift Innovations said, “This is an important stepping stone for the company to enter the North American market. Through this cooperation, we could be able to bring our cutting-edge technologies to our customer’s doorstep where they can test the technology easily for different applications. We are expecting to start some pilot trials for the geothermal brine and produced water treatment in North America in the near future. We are very excited about the opportunity to work with this world-class research institution to facilitate the real lab and pilot trials for our customers and the subsequent commercial opportunities it presents to the company.”

Dr. Jeffrey McCutcheon, Executive Director, CCAST, University of Connecticut said, “We are excited to team up with Memsift to conduct applications testing on their innovative products. We welcome partnerships like this to expand the availability of emerging technology for water treatment and other separations throughout North America.”

Memsift Innovations Pte Ltd is a technology-based company registered in Singapore. Memsift is the developer and manufacturer of the novel vapor transfer membrane STOMATE® and the thermal membrane system TS-30™. Memsift is providing solutions for high strength industrial effluent treatment, liquid-waste volume reduction, resource recovery, brine treatment, zero liquid discharge and aqueous/organic separations for various industries using their proprietary technologies.

The University of Connecticut is a national leader among public research universities, with more than 32,000 students seeking answers to critical questions in classrooms, labs, and the community. The Connecticut Center for Applied Separations Technologies (CCAST), which is located in Innovation Partnership Building IPB at UConn Tech Park at the University of Connecticut, provides contract R&D services that identify energy and cost-efficient solutions for separations needs through thoughtful consideration of innovative materials, differentiating techniques & robust process design.

© Smart Water & Waste World. Send us your editorial contributions at